Biolex
id:
biolex-279-5349361
title:
Biolex
text:
Biolex Therapeutics was a biotechnology firm in the Research Triangle of North Carolina which was founded in 1997 and raised $190 million from investors. It filed for Chapter 7 bankruptcy on July 5, 2012. The company focused on expression of difficult-to-synthesize recombinant proteins in its LEX platform, which used Lemna, a duckweed. The duckweeds are a family of small aquatic plants that can be grown in sterile culture. Biolex developed recombinant DNA technology for efficiently producing pha
brand slug:
wiki
category slug:
encyclopedia
description:
Former American biotechnology firm
original url:
https://en.wikipedia.org/wiki/Biolex
date created:
date modified:
2022-04-28T22:50:52Z
main entity:
{"identifier":"Q4914931","url":"https://www.wikidata.org/entity/Q4914931"}
image:
fields total:
13
integrity:
14